Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-irradiation With Stereotactic Radiosurgery Plus Cetuximab in Recurrent SCCHN
NCT01104922Phase 2Completed
- Start
- Dec 2007
- Primary completion
- May 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in squamous cell carcinoma of the head and neck (HNSCC). Started Dec 2007; status: completed.
02
Drugs
KL-140
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01104922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104922.